Cargando…
ALS drug development guidances and trial guidelines: Consensus and opportunities for alignment
The US Food and Drug Administration (FDA) developed a draft guidance for drug development in amyotrophic lateral sclerosis (ALS) that was issued in February 2018. The FDA draft guidance considered the recommendations developed by the ALS community that incorporated the views of a large group of clin...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656654/ https://www.ncbi.nlm.nih.gov/pubmed/31171646 http://dx.doi.org/10.1212/WNL.0000000000007695 |